These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20837498)

  • 1. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
    Ding T; Ledingham J; Luqmani R; Westlake S; Hyrich K; Lunt M; Kiely P; Bukhari M; Abernethy R; Bosworth A; Ostor A; Gadsby K; McKenna F; Finney D; Dixey J; Deighton C; ;
    Rheumatology (Oxford); 2010 Nov; 49(11):2217-9. PubMed ID: 20837498
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Bhalla AK; Samaranayaka M
    Rheumatology (Oxford); 2008 Oct; 47(10):1591; author reply 1591. PubMed ID: 18676499
    [No Abstract]   [Full Text] [Related]  

  • 3. BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
    Deighton C; Hyrich K; Ding T; Ledingham J; Lunt M; Luqmani R; Kiely P; Bukhari M; Abernethy R; Ostor A; Bosworth A; Gadsby K; McKenna F; Finney D; Dixey J;
    Rheumatology (Oxford); 2010 Jun; 49(6):1197-9. PubMed ID: 20308121
    [No Abstract]   [Full Text] [Related]  

  • 4. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
    Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
    Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
    [No Abstract]   [Full Text] [Related]  

  • 5. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
    Bukhari M; Abernethy R; Deighton C; Ding T; Hyrich K; Lunt M; Luqmani R; Kiely P; Bosworth A; Ledingham J; Ostör A; Gadsby K; McKenna F; Finney D; Dixey J;
    Rheumatology (Oxford); 2011 Dec; 50(12):2311-3. PubMed ID: 21546351
    [No Abstract]   [Full Text] [Related]  

  • 6. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
    Brar A; Hiebert T; El-Gabalawy H
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334
    [No Abstract]   [Full Text] [Related]  

  • 7. BSR Biologics Registry.
    Griffiths I; Silman A; Symmons D; Scott DG
    Rheumatology (Oxford); 2004 Dec; 43(12):1463-4. PubMed ID: 15328420
    [No Abstract]   [Full Text] [Related]  

  • 8. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Chakravarty K; McDonald H; Pullar T; Taggart A; Chalmers R; Oliver S; Mooney J; Somerville M; Bosworth A; Kennedy T; ;
    Rheumatology (Oxford); 2008 Jun; 47(6):924-5. PubMed ID: 16940305
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study.
    Marshall NJ; Wilson G; Lapworth K; Kay LJ
    Rheumatology (Oxford); 2004 Aug; 43(8):1034-8. PubMed ID: 15150436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agents.
    Goupille P; Pham T; Sibilia J; Mariette X
    Semin Arthritis Rheum; 2007 Dec; 37(3):202-3; author reply 203. PubMed ID: 17570470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidance for practitioners on the assessment, administration and monitoring of biologic therapies for inflammatory arthritis.
    Oliver S
    Musculoskeletal Care; 2003 Sep; 1(2):135-40. PubMed ID: 20217674
    [No Abstract]   [Full Text] [Related]  

  • 13. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I
    Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register.
    Kievit W; Fransen J; Adang EM; den Broeder AA; Bernelot Moens HJ; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2011 Jan; 50(1):196-203. PubMed ID: 21078625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
    Coates LC; Tillett W; Chandler D; Helliwell PS; Korendowych E; Kyle S; McInnes IB; Oliver S; Ormerod A; Smith C; Symmons D; Waldron N; McHugh NJ;
    Rheumatology (Oxford); 2013 Oct; 52(10):1754-7. PubMed ID: 23887065
    [No Abstract]   [Full Text] [Related]  

  • 16. Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology.
    Fautrel B; Flipo RM; Saraux A
    Rheumatology (Oxford); 2008 Nov; 47(11):1698-703. PubMed ID: 18794185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma, rheumatoid arthritis, and TNFalpha antagonists.
    Mariette X
    Joint Bone Spine; 2010 May; 77(3):195-7. PubMed ID: 20399132
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapies in rheumatoid arthritis].
    Forster A
    Praxis (Bern 1994); 2003 Mar; 92(11):489-96. PubMed ID: 12698581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience.
    Kaushik VV; Ambalavanan S; Binymin K
    Rheumatology (Oxford); 2007 Dec; 46(12):1863-4; author reply 1864-5. PubMed ID: 17965441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.